1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Phibro Animal Health reported fiscal fourth-quarter and full-year results for the year ended June 30, 2025, with net sales of $1,296.2 million (up 27%) and net income of $48.3 million (up from $2.4 million). The company also issued fiscal 2026 guidance calling for net sales of $1.43 billion to $1.48 billion and net income of $73 million to $83 million, and the results and guidance were released in a press release furnished as Exhibit 99.1.
Q4 net sales were $378.7 million, up 39%, and diluted EPS was $0.42 versus $0.02 a year earlier.
Full-year diluted EPS was $1.19, up $1.13, and adjusted diluted EPS was $2.09, up 76%.
FY2026 guidance includes adjusted EBITDA of $225 million to $235 million and diluted EPS of $1.79 to $2.03.
Management said higher SG&A reflected investments in scaling operations, and gross leverage was 3.1x as of June 30, 2025.
InvenTrust Properties amended its $400 million unsecured term loans and a revolving credit agreement on August 25, 2025, extending maturities and modifying interest rates tied to its leverage ratio. Management said the weighted average maturity rises from 2.9 to 5.1 years, which the company says provides more certainty around its capital structure.
Tranche A-1 ($200 million) now matures August 26, 2030; Tranche A-2 ($200 million) matures February 24, 2031
Margins range from 115 to 160 basis points on SOFR loans, based on the company's leverage ratio
Forward-starting swaps set all-in weighted average fixed rates of 4.50% and 4.58% for the two tranches
Revolving facility amendment removes the credit spread adjustment to SOFR
CooperCompanies reported fiscal third-quarter 2025 results for the period ended July 31, 2025, with revenue up 6% to $1,060.3 million and non-GAAP diluted EPS up 15% to $1.10, while GAAP diluted EPS fell 6% to $0.49. The company raised its fiscal 2025 non-GAAP diluted EPS guidance to $4.08 to $4.12, and CEO Al White said revenues were below expectations and that the company expects improving revenue in the fourth quarter and fiscal 2026. For shareholders, the decline in GAAP earnings and charges tied to a CooperSurgical product line exit sit alongside the higher adjusted earnings outlook.
Revenue of $1,060.3 million, up 6% year over year and up 2% organically; CooperVision revenue was $718.4 million and CooperSurgical revenue was $341.9 million.
GAAP diluted EPS was $0.49, down from $0.52; non-GAAP diluted EPS was $1.10, up from $0.96.
Fiscal 2025 guidance: non-GAAP diluted EPS of $4.08 to $4.12 and total revenue of $4,076 million to $4,096 million.
Repurchased $52.1 million of common stock in the quarter, with $163.6 million of remaining program availability.
Five Below reported second-quarter fiscal 2025 net sales of $1,026.8 million, up 23.7%, and GAAP diluted earnings per share of $0.77, up from $0.60 a year earlier. The company also raised its full-year 2025 sales and earnings per share guidance, which points to higher expected results for shareholders.
Q2 net sales were $1,026.8 million, up 23.7%, with comparable sales up 12.4%
Q2 GAAP diluted EPS was $0.77 versus $0.60; adjusted diluted EPS was $0.81 versus $0.54
Full-year 2025 net sales are now expected at $4.44 billion to $4.52 billion, with diluted EPS of $4.56 to $4.96
Third-quarter 2025 net sales are expected at $950 million to $970 million, with diluted EPS of $0.09 to $0.21
Pure Storage reported second-quarter fiscal 2026 results for the quarter ended August 3, 2025, with revenue of $861.0 million, up 13% year-over-year, and net income of $47.1 million, or $0.14 per diluted share. The company raised its full-year fiscal 2026 revenue and non-GAAP operating income guidance, which signals higher expected sales and profit for shareholders, although GAAP operating income fell sharply from a year earlier.
Revenue of $861.0 million, up 13% year-over-year; subscription services revenue of $414.7 million, up 15%.
GAAP operating income of $4.9 million, compared with $24.9 million a year earlier; non-GAAP operating income of $130.0 million.
Net income of $47.1 million, or $0.14 per diluted share, compared with $35.7 million, or $0.10 per diluted share, a year earlier.
Fiscal 2026 revenue guidance raised to $3.60 billion to $3.63 billion from $3.515 billion; non-GAAP operating income guidance raised to $605 million to $625 million from $595 million.
Agilent reported third-quarter fiscal 2025 revenue of $1.74 billion, up 10.1% reported and 6.1% on a core basis, and GAAP EPS of $1.18, up 22% from a year earlier. Non-GAAP EPS was $1.37, up 4%, and the company revised its full-year revenue outlook to $6.91 billion to $6.93 billion with non-GAAP EPS of $5.56 to $5.59. For shareholders, the filing shows higher revenue and profit and a revised full-year and fourth-quarter outlook.
Q3 revenue of $1.74 billion for the quarter ended July 31, 2025, up 10.1% reported and 6.1% core versus Q3 2024
GAAP EPS of $1.18 versus $0.97 a year earlier; non-GAAP EPS of $1.37 versus $1.32
Full-year fiscal 2025 revenue outlook of $6.91 billion to $6.93 billion; non-GAAP EPS of $5.56 to $5.59
Q4 revenue outlook of $1.822 billion to $1.842 billion; non-GAAP EPS of $1.57 to $1.60
Veeva reported fiscal 2026 second-quarter results for the period ended July 31, 2025, with total revenues up 17% year over year to $789.1 million and GAAP net income up 17% to $200.3 million. The company also gave fiscal third-quarter guidance and updated its full fiscal 2026 revenue and non-GAAP outlook, and its CFO said results for all metrics outperformed prior guidance.
Total revenues were $789.1 million, up from $676.2 million a year earlier; subscription services revenues were $659.2 million, up 17%.
GAAP diluted net income per share was $1.19, compared with $1.04; non-GAAP diluted net income per share was $1.99, compared with $1.62.
GAAP results included $30.6 million in litigation settlement-related charges in the quarter.
Fiscal 2026 total revenue guidance is $3,134 million to $3,140 million; third-quarter total revenue guidance is $790 million to $793 million.
Nutanix reported fourth-quarter fiscal 2025 revenue of $653.3 million, up 19% from a year earlier, and GAAP net income of $38.7 million, compared with a net loss of $126.1 million in the prior-year quarter. The company also issued a separate release saying its Board authorized repurchases of up to $350 million of Class A common stock, and it gave fiscal 2026 and first-quarter outlooks.
Q4 fiscal 2025 revenue was $653.3 million, up 19% from $548.0 million; fiscal 2025 revenue was $2.54 billion, up 18%.
Q4 GAAP net income was $38.7 million, or $0.13 per diluted share, versus a net loss of $126.1 million, or $(0.51) per share, a year earlier.
Fiscal 2025 free cash flow was $750.2 million; fiscal 2026 free cash flow outlook is $790 million to $830 million.
Board authorized repurchases of up to $350 million of Class A common stock; first-quarter fiscal 2026 revenue outlook is $670 million to $680 million.
Williams-Sonoma reported second-quarter 2025 results for the period ended August 3, 2025, with net revenues of $1.84 billion, diluted EPS of $2.00 versus $1.67 a year earlier, and an operating margin of 17.9%. The company raised its fiscal 2025 net revenue outlook but reiterated its operating margin guidance, noting that higher tariff costs will pressure the flow-through of higher revenue.
Net revenues of $1.84 billion versus $1.79 billion in the second quarter of 2024; comparable brand revenue rose 3.7%.
Diluted EPS of $2.00, up 19.8% from $1.67; operating income of $328 million at a 17.9% margin.
Fiscal 2025 net revenue growth outlook raised to +0.5% to +3.5%; operating margin outlook reiterated at 17.4% to 17.8%.
Returned $280 million to stockholders in the quarter, including $199 million in stock repurchases and $81 million in dividends.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.